Mel Rothberg

Vice President and Consultant to the Chief Operating Officer

Professional Overview

Mel Rothberg is a seasoned executive with extensive experience in the biomedical and healthcare industries. As the Vice President and Consultant to the Chief Operating Officer at Quotient Sciences, he leverages his deep industry expertise to provide strategic guidance and operational support to the organization. Rothberg's areas of specialization include new business development, operational optimization, and driving innovative solutions within the biotech and pharmaceutical sectors.

Experience Summary

Current Role

Rothberg currently serves as the Vice President and Consultant to the Chief Operating Officer at Quotient Sciences, a leading global provider of drug development services. In this role, he works closely with the COO to identify and implement strategic initiatives that enhance the company's operational efficiency and position it for continued growth. Rothberg's responsibilities include providing expert counsel on process improvements, overseeing special projects, and collaborating with cross-functional teams to deliver exceptional client outcomes.

Career Progression

Rothberg's distinguished career spans over three decades in the biomedical industry. Prior to his current role, he held executive positions at organizations such as Vaccine and Gene Therapy Institute of Florida, where he served as the Chief Operating Officer, and Viragen, Inc., where he held the role of Executive Vice President of Operations. Rothberg has also founded and led successful entrepreneurial ventures, including Rothberg Associates and Dharma Biomedical LLC, further demonstrating his versatility and strategic acumen.

Academic Background

Rothberg holds a Bachelor's degree in Biomedical Engineering from a prestigious university, providing him with a solid foundation in the technical aspects of the industry.

Areas of Expertise

• New business development and strategic partnerships

• Operational optimization and process improvement

• Biotech and pharmaceutical industry expertise

• Cross-functional team leadership and collaboration

• Entrepreneurial and innovative problem-solving

Professional Impact

Throughout his career, Rothberg has made significant contributions to the biomedical industry. As the CEO of Rothberg Associates and Dharma Biomedical LLC, he has spearheaded the development and commercialization of innovative healthcare solutions. His tenure as the COO of the Vaccine and Gene Therapy Institute of Florida showcased his ability to drive operational excellence and position the organization for continued growth.

Conclusion

Mel Rothberg's extensive experience, diverse expertise, and proven track record of success make him a valuable asset to Quotient Sciences and the broader biomedical industry. As he continues to serve as the Vice President and Consultant to the Chief Operating Officer, Rothberg is poised to contribute to the company's ongoing success and drive positive change within the rapidly evolving healthcare landscape.